|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
JPRN |
|
Last refreshed on:
|
17 October 2023 |
|
Main ID: |
JPRN-UMIN000001973 |
|
Date of registration:
|
15/05/2009 |
|
Prospective Registration:
|
Yes |
|
Primary sponsor: |
|
|
Public title:
|
Effects of d-cycloserine and valproic acid on extinction of fear conditioning or other lerning
|
|
Scientific title:
|
Effects of d-cycloserine and valproic acid on extinction of fear conditioning or other lerning - Effects of d-cycloserine and valproic acid on learning |
|
Date of first enrolment:
|
2009/06/01 |
|
Target sample size:
|
60 |
|
Recruitment status: |
Complete: follow-up complete |
|
URL:
|
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000002408 |
|
Study type:
|
Interventional |
|
Study design:
|
Parallel Randomized
|
|
Phase:
|
Not applicable
|
|
|
Countries of recruitment
|
|
Japan
| | | | | | | |
|
Contacts
|
|
Name:
|
Kenichi Kuriyama |
|
Address:
|
4-1-1 Ogawahigashi, Kodaira, Tokyo 187-8553, Japan
Japan |
|
Telephone:
|
042-346-1986 |
|
Email:
|
|
|
Affiliation:
|
National Institute of Mental Health, National Center of Neurology and Psychiatry Departments of Adult Mental Health |
|
|
Name:
|
Kenichi Kuriyama |
|
Address:
|
4-1-1 Ogawahigashi, Kodaira, Tokyo 187-8553, Japan
Japan |
|
Telephone:
|
042-346-1986 |
|
Email:
|
kenichik@ncnp.go.jp |
|
Affiliation:
|
National Institute of Mental Health, National Center of Neurology and Psychiatry Departments of Adult Mental Health |
| |
|
Key inclusion & exclusion criteria
|
Inclusion criteria:
Exclusion criteria: 1. Having previous histories of drug or alcohol abuse or of neurological, psychiatric, or physiological disorders. 2. Taking an OTC [over-the-counter] drug and/or supplement tablets regularly. 3. Who recognized as unsuitable for testing by physician.
Age minimum:
20years-old
Age maximum:
30years-old
Gender:
Male and Female
|
|
Health Condition(s) or Problem(s) studied
|
|
Healthy volunteers
|
|
Intervention(s)
|
100mg D-cycloserine
400mg Valproic acid
100mg D-cycloserine with 400mg Valproic acid
placebo (inactive substance)
|
|
Primary Outcome(s)
|
|
Participants' physiological responses to the stimuli will be recorded. Electrodes will be placed on two fingers (to measure sweat, or electrodermal activity), on both wrists and a lower leg (to measure heart rate).
|
|
Secondary Outcome(s)
|
|
Accuracy and reaction time to tha memory tasks are also included as secondary ealuation outcomes.
|
|
Source(s) of Monetary Support
|
|
Japan Science and Technology
|
|
Ethics review
|
Status: YES
Approval date:
Contact:
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
01/05/2010 |
|
URL:
|
|
|
|